Martos Sánchez I, Vázquez Martínez J L, Otheo de Tejada E, Ros P
Unidad de Cuidados Intensivos Pediátricos, Hospital Ramón y Cajal, Madrid, España.
An Pediatr (Barc). 2003 Nov;59(5):483-90. doi: 10.1016/s1695-4033(03)78764-5.
The management of hypoxic respiratory failure is based on oxygen delivery and ventilatory support with lung-protective ventilation strategies. Better understanding of acute lung injury have led to new therapeutic approaches that can modify the outcome of these patients. These adjunctive oxygenation strategies include inhaled nitric oxide and surfactant delivery, and the use of prone positioning. Nitric oxide is a selective pulmonary vasodilator that when inhaled, improves oxygenation in clinical situations such as persistent pulmonary hypertension of the newborn, pulmonary hypertension associated with congenital heart disease, and acute respiratory distress syndrome (ARDS). When applied early in ARDS, prone positioning improves distribution of ventilation and reduces the intrapulmonary shunt. The surfactant has dramatically decreased mortality caused by hyaline membrane disease in premature newborns, although the results have been less successful in ARDS. Greater experience is required to determine whether the combination of these treatments will improve the prognosis of these patients.
缺氧性呼吸衰竭的管理基于氧输送和采用肺保护性通气策略的通气支持。对急性肺损伤的深入了解催生了新的治疗方法,这些方法可以改变这些患者的预后。这些辅助氧合策略包括吸入一氧化氮和给予表面活性剂,以及采用俯卧位。一氧化氮是一种选择性肺血管扩张剂,吸入后可改善新生儿持续性肺动脉高压、先天性心脏病相关肺动脉高压和急性呼吸窘迫综合征(ARDS)等临床情况下的氧合。在ARDS早期应用时,俯卧位可改善通气分布并减少肺内分流。表面活性剂已显著降低了早产儿透明膜病所致的死亡率,尽管在ARDS中的效果不太理想。需要更多经验来确定这些治疗方法的联合应用是否会改善这些患者的预后。